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Background: Horses commonly suffer from chronic respiratory disease and are also used in large animal models of
spontaneous or induced airway inflammation. The anti-inflammatory properties of curcumin are largely described but its
low bioavailability precludes its clinical use. NDS27, a lysin salt of curcumin incorporated in beta-cyclodextrine, has high
bioavailability and can be administered by inhalation. The aim of this study was to investigate the effects of inhaled
NDS27 on inflammatory cytokines and proteins in the broncho-alveolar lavage fluid using a model of neutrophilic airway
inflammation.
Methods: Airway neutrophilia was induced in eight horses by inhalation of lipopolysaccharides (LPS). Horses were
treated with either inhalation of NDS27 or with placebo in a randomized cross-over design. Broncho-alveolar lavages
were performed 6 hours after stimulation with LPS. Percentage of neutrophils, concentrations of IL-1β, TNF-α, IL-6, Club
cell secretory protein, myeloperoxidase (MPO) and elastase (ELT) concentrations were determined.
Results: LPS stimulation induced significant increases in neutrophil counts and concentrations of IL-6 (70.2 ± 66.0 pg/ml),
TNF-α (43.9 ± 31.2 pg/ml), MPO (580.9 ± 327.0 ng/ml) and ELT (27.6 ± 16.7 ng/ml). Treatment with NDS27 significantly
prevented the increase in active and total MPO (216.4 ± 118.1 ng/ml) and ELT (5.9 ± 3.2 ng/ml) while there was a trend
towards reduced IL-6 concentration.
Conclusions: Results show that, although not reducing neutrophil recruitment, NDS27 largely abolishes LPS-induced
neutrophil degranulation. Reduced levels of ELT and MPO, as well as reduced MPO activity may have beneficial effects via
a reduced production of reactive oxygen species implicated in chronic inflammation and airway remodeling.
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Horses commonly suffer from recurrent airway obstruc-
tion (RAO) or heaves, which is a severe, potentially de-
bilitating, chronic inflammatory airway disease typically
affecting middle-aged horses [1]. From a clinical point of
view, the disease is characterized by periods of acute ex-
acerbation that are interspersed by periods of remission
when horses are kept away from the causative environ-
ment [1]. Initiated following exposure to organic dusts,
molds, and lipopolysaccharides (LPS) in hay [2], acute* Correspondence: charlotte.sandersen@ulg.ac.be
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inflammation, coughing, periods of labored breathing at
rest and exercise intolerance due to bronchospasm and
mucus accumulation in the airways. The exact immuno-
logical processes responsible for the airway hyper-
reactivity and the persistent airway inflammation are still
under investigation [3,4] and several studies have fo-
cused on cytokine expression profiles [5-9]. It seems that
the equilibrium between pro-and anti-inflammatory fac-
tors is disturbed and shifted towards a pro-inflammatory
profile. Club cell secretory protein (CCSP) is a recog-
nised inhibitor of inflammation in the lung. Both, the
gene expression and protein secretion are depleted in
the airways of symptomatic RAO horses compared withtral. This is an Open Access article distributed under the terms of the Creative
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into luminal neutrophils, potentially inhibiting oxidative
burst and enhancing phagocytosis [11]. Activated neu-
trophils release oxidative enzymes such as NADPH oxi-
dase, myeloperoxidase (MPO) and NO synthase that are
responsible for the in vivo generation of reactive nitro-
gen and oxygen reactive species (RNOS) and several
other proteolytic enzymes such as collagenase, cathepsin
and elastase (ELT) [12,13]. Activation of inflammatory
cells by exposure to exogenous stimulants plays a major
role to tip the balance towards an excess of RNOS pro-
duction [14,15].
Recently, the levels of RNOS in RAO-affected and
clinically healthy horses have been investigated and the
therapeutic use of agents that may reduce the oxidative
stress has been suggested [13]. One of these potential
agents is curcumin, a natural phenolic compound, which
has largely documented anti-inflammatory properties
(for review see Prasad et al. [16]). It has been shown that
curcumin has the ability to reduce the production of
RNOS by stimulated neutrophils through acting as an
RNOS scavenger but also as a direct inhibitor of MPO
and NADPH oxidase [17,18]. A highly water-soluble
form of curcumin called NDS27 was developed by our
team (WO 2009144220 A1). NDS27 is a combination of
a salt of curcuminoid derivative and hydroxypropyl-
beta-cyclodextrin. As curcumin, NDS27 has the ability
to inhibit the oxidant response of neutrophils and the
activity of MPO [19].
NDS27 has been investigated in RAO-affected horses
[20]. Inhalation with NDS27 resulted in decreased neu-
trophil percentages and reduced myeloperoxidase con-
centration in broncho-alveolar lavage fluids (BALF)
relative to sham-treated horses.
LPS-induced neutrophilic inflammation plays a key
role in the pathogenesis of RAO in horses [2] and lung
inflammation in other species. Experimental inhalation
of LPS is commonly used as a model of neutrophilic
lung inflammation mimicking natural disease. Inhaled
endotoxins are an important cause of human pulmonary
disease, with the severity of pulmonary inflammation
and clinical symptoms experienced by subjects exposed
to organic dusts being related to the endotoxin concen-
tration in the inhaled dust [21]. Consistent with endo-
toxin inhalation studies in humans and other species
[21], inhalation of 20, 200 and 2000 μg soluble Salmon-
ella typhimurium Ra60 LPS induced a dose-dependent
airway neutrophilia, with BALF neutrophil numbers in-
creasing approximately 50-fold in heaves horses at 6 h
after the high dose challenge [22].
The horses’ susceptibility to develop airway inflamma-
tion, as well as the ease by which the airway inflamma-
tion can be induced in healthy horses, make the horse
an ideal model for testing drugs by inhalation. Althoughnot very popular compared to murine models of respira-
tory disease, horses have some considerable advantages
over smaller laboratory animals [23]. Horses naturally
develop heaves which is characterized by stable dust-
induced inflammation, bronchospasm, and remodelling.
Horses can be evaluated during well-controlled natural
antigen exposure allowing the study of disease mecha-
nisms in the asymptomatic and symptomatic stages. Fur-
ther, the disease can be followed over longer periods to
evaluate the cumulative effect of repeated episodes of
clinical exacerbation and of long-term treatment. Horses
can easily be exposed to inhalation challenges and re-
peated broncho-alveolar lavages can be performed in the
same animal. LPS challenge and especially naturally oc-
curring heaves share similarities with the human asthma
and the equine model is currently being used to evaluate
airway remodelling [23].
The aim of this study was to test the effect of NDS27
on the BALF concentration of several pro-inflammatory
cytokines, the neutrophil enzymes MPO and elastase,
and the anti-inflammatory protein CCSP in an equine
model of LPS-induced lung neutrophilia.
Methods
Animals
The study was approved by the institutional committee
of animal use (Commission d’Ethique Animale de l’Uni-
versité de Liège, Protocol 11-1137). Eight clinically
healthy adult Standardbred horses with no history of
RAO were included in this study. All horses were main-
tained on pasture for at least two months without sup-
plementation of hay and underwent a thorough physical
examination, complete blood count and airway endos-
copy before the beginning of the study.
Study protocol
The control BALs were performed on eight horses with-
out any treatment while they were kept on pasture
(CTRL). Three weeks later, the horses were randomly
assigned to both stimulation and placebo (STIM) or
both stimulation and treatment (NDS27) groups. After a
washout period of three weeks horses received the other
treatment.
Horses of both groups were challenged with 2 mg of
LPS (Sigma-Aldrich, Belgium) diluted in 4 ml of NaCl
(0.9%) given via inhalation (SaHoMa, Nebu-tec, Germany)
at T0. They received placebo or treatment at one hour be-
fore and two and four hours after challenge. Each dose of
NDS27 contained 4 mg of curcumin, 49.8 mg of hydroxy-
propylbeta-cyclodextrin and 1.1 mg of lysine base. Each
dose of the placebo treatment contained 49.8 mg of
hydroxy-propylbeta-cyclodextrin and 1.1 mg of lysine
base. Each dose was diluted in 4 ml of NaCl 0.9% before
administration by inhalation (Flexineb, Nortex, UK). In all
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(T + 6 h).
Broncho-alveolar lavages
All BALs were performed as follows: horses were se-
dated with detomidine (Domidine, Eurovet, Heusden-
Zolder, Belgium) at a dose of 10 μg/kg intravenously. A
broncho-alveolar catheter (BAL catheter 240 cm, Surgivet,
Smith Medical, Zaventem, Belgium) was introduced
naso-tracheally and forwarded until it became locked in
a bronchus. Warmed sterile saline solution (240 ml)
was injected and gently aspirated. The amount of re-
covered fluid was recorded. From the recovered fluid,
9 ml were transferred to an EDTA-tube and centri-
fuged. The supernatant was kept frozen at-20°C until
analyses. A different aliquot served for determination
of total nucleated cell count with the help of a Thomas
chamber. From the original BAL sample 100 μL were
used to generate a centrifuged slide (Cytospin, Terumo,
Belgium) that was Giemsa-stained. Two investigators
unaware of the treatment performed differential cell
counts by identifying 400 cells under light microscopy.
The mean of the two counts were used for statistical
analyses.
Sandwich ELISA for equine TNF-α
BALF TNF-α concentration was determined by a sand-
wich ELISA kit designed and validated specifically for
equine samples (Equine TNF-α, Genorise, USA). The
assay was performed according to manufacturer’s in-
structions. Each sample was assayed twice and the mean
value was calculated. Calibration samples and non-
diluted EDTA samples were incubated 1 hour at 22°C.
Sandwich ELISA for equine IL1-β and IL-6
BALF concentrations of IL1-β and IL-6 were deter-
mined by a sandwich ELISA kit designed and validated
specifically for equine samples (Genorise, USA). The
assay was performed according to manufacturer’s in-
structions. Each sample was assayed twice and the
mean value was calculated. Calibration curves and non-
diluted EDTA samples were incubated 2 h at 37°C.
CCSP assay
Concentration of CCSP in BALF fluid was determined
as described previously [10]. Briefly, 100 μL of reCCSP
(0, 12.5, 25, 50, 100 and 200 ng/mL) or BALF were
placed in wells overnight at 4°C. Next day, wells were
washed, 100 μL of eCCSP-AB (a rabbit anti-equine
CCSP antibody, diluted 1:350) was added for 1 hour at
room temperature, wells were washed again, and horse-
radish peroxidase-labeled swine anti-rabbit polyclonal
antibody (Dako) was added. Finally, 100 μL of tetra-
methylbenzidine (Pierce, Rockford, IL) was added toeach well, plates were incubated for 15 minutes, and
the reaction was terminated by addition of 100 μL of
0.5 M sulfuric acid. Absorbance was measured at
450 nm. Incubation of samples with pre-immune rabbit
serum in lieu of eCCSP-AB served as a negative con-
trol, and readings from blank wells were used to deter-
mine background signal. All samples and standards
were tested in triplicate. Standard curve analysis was
used to extrapolate sample CCSP concentrations.
Sandwich ELISA for equine myeloperoxidase (MPO)
Concentration of MPO in BALF was determined by a
commercially available ELISA kit (Equine MPO ELISA kit,
BiopTis, Belgium) developed by Franck at el., [24]. Equine
MPO standards ranging from 0.78–50 ng/ml and EDTA
BALF were added (100 μl) into the wells, and microplates
were incubated overnight at 4°C. The secondary antibody
was labeled with alkaline phosphatase and the revelation
system used a paranitrophenyl phosphate-stabilized solu-
tion. The absorbance was directly proportional to the
MPO captured by the primary antibody and, therefore, to
the concentration of MPO in the sample. Each sample
was assayed twice and the mean value was calculated.
Sandwich ELISA for equine elastase (ELT)
A specific ELISA for equine neutrophil ELT developed
by de la Rebière de Pouyade et al. (2010) [25] was used
for measurement of ELT concentration in BALF (Equine
ELT ELISA kit, BiopTis, Belgium). Equine elastase stan-
dards ranging from 1.875–60 ng/ml and EDTA BALF
were added (100 μl) into the wells, and microplates were
incubated overnight at 4°C. The secondary antibody was
labeled with alkaline phosphatase and the detection sys-
tem used a paranitrophenyl phosphate-stabilized solu-
tion. The absorbance was directly proportional to the
ELT captured by the primary antibody and, therefore, to
the concentration of ELT in the sample. Each sample
was assayed twice and the mean value was calculated.
Specific immuno extraction followed by enzymatic
detection (SIEFED) assay for measurement of MPO activity
MPO activity was measured to determine the possible
mechanism of action of NDS27. The SIEFED method
allows the capture of MPO from biological fluids by
microplate-coated specific antibodies. The fluid is elim-
inated by washings and the in situ activity of the en-
zyme is determined by a combination of a fluorogenic
substrate (Amplex red) and a nitrite-based amplifier
system. The primary antibody (rabbit anti-MPO IgG)
was coated onto black microplate wells. Equine MPO
standards (ranging from 0.25 to 6.4 mU/mL) and non-
diluted samples containing MPO (100 μL) were added
to the microplate and incubated for 2 hours at 37°C.
After 3 washings, the peroxidase activity of MPO was
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acetyl-3, 7-dihydroxyphenoxazine), freshly prepared in
phosphate buffer (50 mM) at pH 7.5 containing 10 μM
H2O2 and 10 mM nitrite. Fluorescence was measured with
a fluorescence plate reader (Fluoroscan Ascent, Fischer
Scientific) at the excitation and emission wavelengths of
544 and 590 nm. Each sample was run in duplicate.
The fluorescence value is directly proportional to the
quantity of active MPO in the sample.
Statistical analysis
An analysis of variance on repeated measurements was
used for each parameter to compare the mean values of
the control group, the STIM group and the NDS27 group.
A sphericity test was used to assess the equality of vari-
ances of the differences between measurements [26]. The
multiple pairwise comparisons were performed by a Bon-
feroni test. All the tests were performed with commer-
cially available software (MedCalc Software, Oostende,
Belgium) with the level of significant set at < 0.05.
Results
All horses tolerated challenge with LPS and inhalation
of NDS27 without any sign of discomfort. Median total
nucleated cell counts were 92.5 cells/μL (range: 75–115)
for the control group, 325 cells/μL (range: 215–355) for
the STIM group and 321 cells/μL (range: 285–360) for
the NDS27 group. Relative neutrophil counts in BALF
are displayed in Figure 1. Stimulation with LPS led to
significantly higher mean relative neutrophil counts of
55 ± 6% in the stimulation only group and 46 ± 4% in
the group treated with NDS27. Although lower in the
NDS27 group, relative neutrophil count was not signifi-
cantly different between the treatment groups.*
Figure 1 Relative neutrophil counts in broncho-alveolar lavage fluids from 8
treatment with NDS27 or saline. CTRL, control group; STIM, stimulation with L
with NDS27. *Significantly different (p < 0.05) from CTRL group.Mean concentrations (± standard error) of the cyto-
kines of IL-6 and TNF-α are displayed in Figure 2a
and b, respectively. Stimulation with LPS significantly
increased concentrations of both cytokines in BALF.
Although not statistically significant, there was a trend
towards a decrease of IL-6 in the BALF of the NDS27
treatment group when compared to the STIM group
(p = 0.06).
Half of the samples were below the limit of detection
for the measurement of IL-1β. For the remaining sam-
ples, mean concentration of IL-1β was 6.09 ± 1.86 pg/ml
in the CTRL group, while it was 0.75 ± 0.57 pg/mL in
the STIM group and 2.76 ± 1.29 pg/mL in the NDS27
group. There were no significant differences between the
three groups.
Results for mean concentration (± standard error) of
MPO and ELT in BALF are displayed in Figure 3a and b,
respectively. Both degranulation products are found in sig-
nificantly higher concentrations in BALF of LPS-stimulated
horses when compared to CTRL group. Treatment with
NDS27 abolished this increase in led to significantly lower
levels of both enzymes when compared to the placebo
treated group. Mean concentrations of active MPO in
BALF was significantly higher in the STIM group than in
the NDS27 group, as displayed in Figure 4. Measurement
of active MPO was unavailable in the CTRL group.
There were no significant differences between the
three groups concerning concentration of CCSP in the
BALF as shown in Figure 5.
Discussion
Inhalation of LPS has previously been used to induce neu-
trophilic airway inflammation in humans [27], laboratory
animals [28], and horses [22,29]. Several studies have*
horses at baseline, after stimulation with lipopolysaccharide aerosol and
PS and treatment with saline; NDS27, stimulation with LPS and treatment
Figure 2 Concentrations of (a) interleukin-6 (IL-6) and (b) tumor necrosis factor-α (TNF-α) in broncho-alveolar lavage fluids from 8 horses at
baseline, after stimulation with lipopolysaccharide aerosol and treatment with NDS27 or saline. CTRL, control group; STIM, stimulation with LPS
and treatment with saline; NDS27, stimulation with LPS and treatment with NDS27. *Significantly different (p < 0.05) from CTRL group.
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phil counts and increased neutrophil ratios in BALF six
hours after the challenge in healthy horses [22,29].
Concentration of TNF-α, IL-1, IL-6, IL-8, and IL-10
was increased in the BALF from horses challenged by
LPS, although these changes were lower than in horses
challenged with hay dust solution [22]. LPS inhalation
increases the concentration of metallo-matrix protein-
ases in BALF suggesting their role in tissue remodeling
[30]. Lipopolysaccharides are TLR4 agonists that acti-
vate NFκB dependent cytokine production [27] as well
as induce release of TNF-α from macrophages. TNF-α
is also responsible for neutrophil recruitment. In the
present study, inhalation of LPS induced significant
increases in the mean percentage of neutrophils, and in
the mean concentrations of MPO, ELT, TNF-α and IL-
6 in BALF when compared to control values. This find-
ing is largely consistent with findings of earlier studies
and underlies the usefulness of the universal model of
LPS-induced neutrophilic airway inflammation. The
neutrophilic enzymes MPO and ELT have not previ-
ously been studied in an LPS model in horses but MPO
has been measured in BALF of horses naturally affected
by RAO [31]; as well as in BALF of LPS-challenged rats
[32] and mice [33]. In the present study no change in*
#
a
Figure 3 Concentration of (a) myeloperoxidase (MPO) and (b) elastase (EL
stimulation with lipopolysaccharide aerosol and treatment with NDS27 or s
with saline; NDS27, stimulation with LPS and treatment with NDS27. *Signi
(p < 0.05) between the STIM and the NDS27 group.IL-1β was induced by stimulation with LPS aerosol.
This is contradictory to previous studies in mice [34,35]
but can be explained by insufficient sensitivity of the
ELISA kit for detection of IL-1β in un-concentrated
BALF. A potential effect of NDS27 on IL-1β could,
therefore, not be investigated. Unfortunately, more sen-
sitive methods such as real time polymerase chain reac-
tion analysis (PCR) were not performed in the present
study. PCR analysis would have also allowed investiga-
tion of other cytokines and degranulation markers such
as matrix metalloproteinases.
We have previously showed that inhalation of NDS27
attenuates pulmonary neutrophilic inflammation in RAO-
affected horses [20]. It was hypothesized that NDS27
mediated pro-apoptotic mechanisms inhibited the tran-
scription factor NF-κB or decreased the neutrophil efflux
into the lung. In the present work, the effect of inhaled
NDS27 on inflammatory cytokines and enzymes in the
BALF of horses submitted to a LPS-model of neutrophilic
airway inflammation was evaluated. Treatment with
NDS27 significantly reduced MPO, active MPO and ELT
concentrations in BALF, compared to the non-treated
group, while it had no significant effect on neutrophil re-
cruitment. The previous study was performed on naturally
affected RAO-horses, which are mainly suffering from#
b
T) in broncho-alveolar lavage fluids from 8 horses at baseline, after
aline. CTRL, control group; STIM, stimulation with LPS and treatment













Figure 4 Concentration of active myeloperoxidase activity (MPOact) in broncho-alveolar lavage fluids from 8 horses after stimulation with lipopolysac
charide aerosol and treatment with NDS27 or saline. STIM, stimulation with LPS and treatment with saline; NDS27, stimulation with LPS and treatment with
NDS27. # Significant difference (p < 0.05) between the STIM and the NDS27 group.
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duced relative neutrophil counts after one week of twice
daily NDS27 treatment. Comparing the results of both
studies, hay-dust induced RAO and LPS-induced lung
neutrophilia, it seems that NDS27 is more effective in
clearing persistent inflammation than impeding initial
neutrophil recruitment.
Numerous studies showed that curcumins have the
ability to control the inflammatory response via either
the inhibition of the release or expression of inflamma-
tory cytokines such Il-6, TNF- α, or by decreasing the
activity and release of inflammatory enzymes. Indeed,
in vitro studies showed that curcumin regulates activa-
tion of some receptors and transcription factors such as
TLR4, activating protein-1 and NF-κB in stimulated
monocytes and alveolar macrophages, thereby blocking
expression of cytokine gene expression [36-38]. Down-










Figure 5 Concentration of Club cell secretory protein (CCSP) in bronch
lipopolysaccharide aerosol and treatment with NDS27 or saline. CTRL, c
NDS27, stimulation with LPS and treatment with NDS27.protein kinase C, may be another way in which curcu-
min inhibits cytokine production [37]. Additionally, the
soluble form of curcumin abolished the stimulating ef-
fect of LPS on neutrophil stimulation and even de-
creased the release of two enzymes considered as typical
markers of neutrophils stimulation such MPO and ELT.
It was showed that the binding site for curcumin overlaps
with the binding site for LPS and that curcumin binds at
submicromolar affinity to the myeloid differentiation pro-
tein 2 (MD2), which is the LPS-binding component of the
endotoxin surface receptor complex MD-2/TLR4 [39].
Since NDS27 could also enter the neutrophil [19], it is not
excluded that the molecule could interfere with other
intracellular pathways involved in the cascade of NADPH
activation and degranulation. Beside a scavenging effect of
curcumin and NDS27 on RNOS produced by neutrophils,
our recent in vitro studies showed that curcumin had
the ability to inhibit the assembly and activity of theIM NDS27
(ng/ml)
o-alveolar lavage fluids from 8 horses after stimulation with
ontrol group; STIM, stimulation with LPS and treatment with saline;
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soluble form inhibited the release and the activity of
MPO [18].
In the present study, treatment with NDS27 was initia-
lised before stimulation with LPS27, which is not reflect-
ing clinical conditions where insult would happen before
the treatment. However, in experimental settings it is not
uncommon to start treatment before the challenge with
LPS. This has been done in a study, where curcumin was
administered one hour before the administration of LPS in
order to induce acute lung injury in mice [40]. Pre-
treatment with curcumin reduced neutrophil recruitment,
MPO activity, TNF-α concentration, and capillary leakage
in response to LPS challenge when compared to treatment
with placebo. Interestingly, treatment with curcumin per-
formed almost as good as standard dexamethasone treat-
ment. The rationale for investigating the effect on CCSP
was based on its potent anti-inflammatory properties as
demonstrated in several studies. Glucocorticoids are
largely considered as mainstay therapy for equine RAO
and are known to act on the CCSP promoter [41]. It has
been shown previously that LPS decreases expression of
CCSP in lung tissue and that this decrease is attenuated
by pretreatment with plant-derived antioxidants such as
polydatin, a natural precursor of resveratrol [42]. However,
CCSP production is likely reduced in horses only as a
result of long-standing lung inflammation and reduction
in the number of Club cells [10]; therefore, absence of sig-
nificant changes within a few hours after treatment was
not unexpected.
Conclusions
The main effect observed in this study is that NDS27
reduced neutrophil activation of LPS-induced airway
inflammation, which subsequently reduced the oxidative
and proteolytic enzyme concentrations in the BALF. Bene-
ficial effects of a prolonged administration of NDS27 may
be expected in clinical situations with persistent airway
inflammation.
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